{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-005701","form_type":"8-K","ticker":"EYPT","cik":"0001314102","company_name":"EyePoint, Inc.","filed_at":"2023-03-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.349129+00:00","generated_at":"2026-06-18T14:26:43.709469+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"EyePoint FY2022 net product revenue $39.9M (+13% YoY); net loss $102.3M; cash $144.6M","bullets":["FY2022 net product revenue $39.9M, up 13% from $35.3M; YUTIQ revenue $28.3M (+67% vs 2021).","Net loss $102.3M ($2.74/share) vs $58.4M ($2.03/share) in FY2021; includes $20.7M DEXYCU impairment.","Cash and investments $144.6M at Dec 31, 2022; cash runway projected into 2H 2024.","Phase 2 DAVIO 2 (wet AMD) topline data expected by year-end 2023; Phase 2 PAVIA (NPDR) enrollment completion in Q4 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-005701","json":"https://secwatch.observer/filing/0000950170-23-005701.json","markdown":"https://secwatch.observer/filing/0000950170-23-005701.md","text":"https://secwatch.observer/filing/0000950170-23-005701.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023005701/0000950170-23-005701-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023005701/eypt-20230302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T14:26:43.709469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5e7470af3d17bd1b35437cdcf6b3ab4021a0a94a","claim":"EyePoint, Inc. reported the fiscal year ended December 31, 2022 results: revenue $41.4 million.","evidence_excerpt":"For the full year ended December 31, 2022, total net revenue was $41.4 million compared to $36.9 million for the full year ended December 31, 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023005701/0000950170-23-005701-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$41.4 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"9c737b9be41c241bfcac49972eb474c53364fa2a","claim":"EyePoint, Inc. reported the quarter ended December 31, 2022 results: revenue $10.5 million, net income $43.5 million, EPS ($1.16) per share.","evidence_excerpt":"For the quarter ended December 31, 2022, total net revenue was $10.5 million compared to $11.5 million for the quarter ended December 31, 2021.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1314102/000095017023005701/0000950170-23-005701-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2022"},{"label":"Revenue","value":"$10.5 million"},{"label":"Net income","value":"$43.5 million"},{"label":"EPS","value":"($1.16) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}